IOVANCE BIOTHERAPEUTICS, INC. Other Non-Current Liabilities
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Other Non-Current Liabilities of $11.71 million as of 2020-12-31, per its 10-K filed 2022-02-24.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-02-24
- 2020-12-31: Other Liabilities, Noncurrent $11.71M.
- 2020-09-30: Other Liabilities, Noncurrent $2.35M.
- 2020-06-30: Other Liabilities, Noncurrent $2.35M.
- 2020-03-31: Other Liabilities, Noncurrent $2.35M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2020-12-31 | $11.71M 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.35M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.35M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.35M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $2.35M 10-K · filed 2021-02-25 |
| 2019-09-30 | $53.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $53.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $53.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $230.00K 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |